Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,679 | 376 | 99.9% |
| Education | $4.90 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,685 | 79 | $0 (2024) |
| Amgen Inc. | $669.51 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $642.83 | 34 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $609.55 | 33 | $0 (2024) |
| Lilly USA, LLC | $462.50 | 24 | $0 (2024) |
| Amarin Pharma Inc. | $381.22 | 18 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $337.64 | 16 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $309.94 | 14 | $0 (2019) |
| Novo Nordisk Inc | $289.64 | 14 | $0 (2022) |
| Allergan, Inc. | $230.88 | 13 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $803.42 | 30 | ABBVIE INC. ($213.63) |
| 2023 | $644.51 | 28 | ABBVIE INC. ($215.62) |
| 2022 | $1,025 | 49 | ABBVIE INC. ($321.38) |
| 2021 | $1,424 | 72 | AbbVie Inc. ($744.39) |
| 2020 | $657.40 | 39 | AbbVie Inc. ($165.71) |
| 2019 | $1,123 | 58 | Sunovion Pharmaceuticals Inc. ($144.97) |
| 2018 | $986.63 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($129.61) |
| 2017 | $1,019 | 49 | Kowa Pharmaceuticals America, Inc. ($159.09) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: VACCINES | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,632 | 2,825 | $640,776 | $141,278 |
| 2022 | 17 | 1,854 | 2,551 | $582,078 | $120,377 |
| 2021 | 17 | 3,639 | 4,360 | $676,417 | $175,578 |
| 2020 | 17 | 1,092 | 1,696 | $485,440 | $88,280 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 502 | $276,100 | $53,818 | 19.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 194 | 194 | $47,412 | $24,925 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 141 | 141 | $90,522 | $21,383 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 177 | $66,375 | $12,846 | 19.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 194 | 194 | $51,728 | $9,244 | 17.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 72 | 72 | $12,050 | $5,447 | 45.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 308 | 480 | $9,940 | $4,032 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 72 | $7,776 | $2,573 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $18,943 | $2,336 | 12.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 165 | 175 | $25,375 | $2,031 | 8.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 111 | $30,525 | $1,398 | 4.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 24 | 24 | $3,120 | $1,144 | 36.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 20 | 93 | $910.02 | $100.85 | 11.1% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 24 | 24 | $0.24 | $0.24 | 100.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 547 | $0.16 | $0.15 | 93.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 479 | $263,450 | $51,727 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 152 | 244 | $91,500 | $18,562 | 20.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 103 | 103 | $66,126 | $16,159 | 24.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 223 | 223 | $28,990 | $10,376 | 35.8% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 110 | 110 | $14,300 | $5,163 | 36.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 65 | 66 | $9,570 | $4,625 | 48.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $21,934 | $3,224 | 14.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 68 | $7,344 | $2,413 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 38 | $9,720 | $1,988 | 20.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 146 | 154 | $22,330 | $1,768 | 7.9% |
About Dr. Faina Kogan, MD
Dr. Faina Kogan, MD is a Geriatric Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1144374380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faina Kogan, MD has received a total of $7,683 in payments from pharmaceutical and medical device companies, with $803.42 received in 2024. These payments were reported across 377 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,679).
As a Medicare-enrolled provider, Kogan has provided services to 8,217 Medicare beneficiaries, totaling 11,432 services with total Medicare billing of $525,513. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Brooklyn, NY
- Active Since 01/23/2007
- Last Updated 04/05/2021
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1144374380
Products in Payments
- Vascepa (Drug) $381.22
- RINVOQ (Biological) $361.62
- UBRELVY (Drug) $330.78
- Livalo (Drug) $309.94
- TRELEGY ELLIPTA (Drug) $286.66
- VRAYLAR (Drug) $273.19
- FARXIGA (Drug) $271.86
- PENNSAID (Drug) $246.95
- JARDIANCE (Drug) $210.74
- SYMBICORT (Drug) $208.55
- LONHALA MAGNAIR (Drug) $199.92
- QULIPTA (Drug) $194.30
- CREON (Drug) $192.72
- Otezla (Drug) $176.24
- Repatha (Biological) $167.88
- MOUNJARO (Drug) $150.27
- BREO (Drug) $147.55
- INVOKANA (Drug) $146.99
- TRULICITY (Drug) $142.31
- LINZESS (Drug) $134.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Brooklyn
Dr. Inna Shifrin, Md, MD
Geriatric Medicine — Payments: $22,730
Nathalia Idelevitch, M.d, M.D
Geriatric Medicine — Payments: $9,941
Dr. William Putman, M.d., Facp, M.D., FACP
Geriatric Medicine — Payments: $9,684
Sergey Genkin, M.d, M.D
Geriatric Medicine — Payments: $8,573
Diana Levina, M.d, M.D
Geriatric Medicine — Payments: $8,258
Larissa Gold, M.d, M.D
Geriatric Medicine — Payments: $7,845